Protein Kinases
- Name
- Protein Kinases
- Accession Number
- DBCAT002979
- Description
A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein.
- Drugs
Drug Drug Description Nelipepimut-S Investigated for use/treatment in prostate cancer and breast cancer. Luspatercept An erythroid maturation agent used to treat anemia secondary to beta thalassemia, myelodysplastic syndromes, and neoplasms. Dalantercept Dalantercept is under investigation in clinical trial NCT00996957 (Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma). VEGFR2-169 VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)). - Drugs & Drug Targets
Drug Target Type Nelipepimut-S HLA class I histocompatibility antigen, A-2 alpha chain target Nelipepimut-S HLA class I histocompatibility antigen, A-3 alpha chain target